Assyro AI

Orange Book product · Brand (NDA)

DATSCAN

IOFLUPANE I-123

Brand (NDA)NDA 022454TE APRX GE HLTHCARE INC

At a glance

Jan 14, 2011

Approved

Brand (NDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 14, 2011

    15 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IOFLUPANE I-123

Strength

5mCi/2.5ML (2mCi/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

AP

Application

NDA 022454

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.